These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1363963)

  • 1. Valproic acid induced abnormal development of the central nervous system of three species of amphibians: implications for neural tube defects and alternative experimental systems.
    Oberemm A; Kirschbaum F
    Teratog Carcinog Mutagen; 1992; 12(6):251-62. PubMed ID: 1363963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the antiepileptic drug valproic acid on the development of the axolotl (Ambystoma mexicanum): histological investigations.
    Krätke R; Kirschbaum F
    Teratog Carcinog Mutagen; 1996; 16(3):149-67. PubMed ID: 8983118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects.
    Akimova D; Wlodarczyk BJ; Lin Y; Ross ME; Finnell RH; Chen Q; Gross SS
    Birth Defects Res; 2017 Jan; 109(2):106-119. PubMed ID: 27860192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of valproic acid on Xenopus laevis development: teratogenic effects on eyes.
    Pennati R; Groppelli S; de Bernardi F; Sotgia C
    Teratog Carcinog Mutagen; 2001; 21(2):121-33. PubMed ID: 11223890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects.
    Tung EW; Winn LM
    Mol Pharmacol; 2011 Dec; 80(6):979-87. PubMed ID: 21868484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
    Dawson JE; Raymond AM; Winn LM
    Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRF2 activation inhibits valproic acid-induced neural tube defects in mice.
    Piorczynski TB; Lapehn S; Ringer KP; Allen SA; Johnson GA; Call K; Lucas SM; Harris C; Hansen JM
    Neurotoxicol Teratol; 2022; 89():107039. PubMed ID: 34737154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid-induced alterations in growth and neurotrophic factor gene expression in murine embryos [corrected].
    Bennett GD; Wlodarczyk B; Calvin JA; Craig JC; Finnell RH
    Reprod Toxicol; 2000; 14(1):1-11. PubMed ID: 10689198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione status and the incidence of neural tube defects elicited by direct acting teratogens in vitro.
    Harris C; Stark KL; Juchau MR
    Teratology; 1988 Jun; 37(6):577-90. PubMed ID: 3135633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
    Padmanabhan R; Shafiullah MM
    Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
    Nau H; Hauck RS; Ehlers K
    Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of small ions during the early development of Xenopus laevis and Ambystoma mexicanum embryos.
    Gillespie JI
    J Physiol; 1983 Nov; 344():359-77. PubMed ID: 6655587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
    Okada A; Kushima K; Aoki Y; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2005 Apr; 73(4):229-38. PubMed ID: 15799026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid disrupts the biomechanics of late spinal neural tube closure in mouse embryos.
    Hughes A; Greene NDE; Copp AJ; Galea GL
    Mech Dev; 2018 Feb; 149():20-26. PubMed ID: 29225143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational exposure to valproic acid upregulates total Stat3 protein expression while downregulating phosphorylated Stat3 in CD-1 mouse embryos with neural tube defects.
    Shafique S; Winn LM
    Birth Defects Res; 2020 Apr; 112(7):555-568. PubMed ID: 32134217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos.
    Padmanabhan R; Shafiullah M; Benedict S; Nagelkerke N
    Eur J Nutr; 2006 Sep; 45(6):311-9. PubMed ID: 16699836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.
    Hishida R; Nau H
    Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro neuroteratogenicity of valproic acid and 4-en-VPA.
    Gofflot F; Nassogne MC; Etzion T; Van Maele-Fabry G; Evrard P; Picard JJ
    Neurotoxicol Teratol; 1995; 17(4):425-35. PubMed ID: 7565489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V; Wlodarczyk B; Giavini E; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.